Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). The first 'Breakthrough Device Designation' received by Concept Medical Inc. was on 30th April 2019 for its MagicTouch SCB, for the treatment of Coronary Artery Disease (CAD) in patients with in-stent restenosis.

The global vascular and non-vascular market is valued at $8.3 billion in 2014. This report analyzes the stent market in terms of market revenue ($ million) for all segments.

Netscribes, Inc. launches a report on Coronary Stents Market in India 2013 covering a market with strong growth potential. It is a part of Netscribes' Healthcare Industry Series.

South Asians were found to be particularly more likely to add visceral fat, which can lead to coronary artery disease and metabolic disorders like diabetes.

Neograft Technologies, Inc., a medical device company developing advanced cardiac technologies for use in heart bypass procedures, announced successful completion of a $5 Million equity offering on July 29, 2011.

Cholesterol Education Month increases awareness about the link between cholesterol and heart disease, and educates individuals about the importance of lipoprotein testing in detecting risks, as performed at the Center for Cholesterol Management.